← العودة إلى الصفحة الرئيسية
الولايات المتحدة · وكالات وأخبار لحظية · PR Newswire

ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026

نشره PR Newswire · الولايات المتحدة منذ 1 س

SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative…

اقرأ المقال كاملًا على PR Newswire سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.prnewswire.com)

يستحق القراءة أيضًا

Business Wire

Chamberlain University Opens First Utah Campus and 26th Location Nationwide, Expanding Nursing Education in the State with the Fewest Nurses per Capita

 Associated Press (Business)

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

 Dow Jones Newswires

Advancing Government Intelligence: Insights From the Data and Intelligence Training Forum

 MT Newswires

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows